alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 86, Number 180 (Tuesday, September 21, 2021)]
[Notices]
[Pages 52470-52471]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20428]


-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Notice of Proposals To Engage in or To Acquire Companies Engaged 
in Permissible Nonbanking Activities

    The companies listed in this notice have given notice under section 
4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and 
Regulation Y, (12 CFR part 225) to engage de novo, or to acquire or 
control voting securities or assets of a company, including the 
companies listed below, that engages either directly or through a 
subsidiary or other company, in a nonbanking activity that is listed in 
Sec.  225.28 of Regulation Y (12 CFR 225.28) or that the Board has 
determined by Order to be closely related to banking and permissible 
for bank holding companies. Unless otherwise noted, these activities 
will be conducted throughout the United States.
    The public portions of the applications listed below, as well as 
other related filings required by the Board, if any, are available for 
immediate inspection at the Federal Reserve Bank(s) indicated below and 
at the offices of the Board of Governors. This information may also be 
obtained on an expedited basis, upon request, by contacting the 
appropriate Federal Reserve Bank and from the Board's Freedom of 
Information Office at https://www.federalreserve.gov/foia/request.htm. 
Interested persons may express their views in writing on the question 
whether the proposal complies with the standards of section 4 of the 
BHC Act.
    Unless otherwise noted, comments regarding the applications must be 
received at the Reserve Bank indicated or the offices of the Board of 
Governors, Ann E. Misback, Secretary of the Board, 20th Street and 
Constitution Avenue NW, Washington, DC 20551-0001, not later than 
October 6, 2021.

[[Page 52471]]

    A. Federal Reserve Bank of Kansas City (Jeffrey Imgarten, Assistant 
Vice President) 1 Memorial Drive, Kansas City, Missouri 64198-0001:
    1. Olney Bancshares of Texas, Inc., Olney, Texas; to engage, de 
novo, in extending credit and servicing loans pursuant to section 
225.28(b)(1) of the Board's Regulation Y.

    Board of Governors of the Federal Reserve System, September 16, 
2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2021-20428 Filed 9-20-21; 8:45 am]
BILLING CODE P
#### In the Matter of Terra Homes, Inc., Respondent, v Henry W. Rose et al., Appellants. (Proceeding No. 1.) In the Matter of Terra Homes, Inc., Respondent, v Henry W. Rose et al., Appellants. (Proceeding No. 2.)

In two proceedings pursuant to CPLR article 78 to review determinations of the Board of Zoning Appeals of the Town of Hempstead (hereinafter the board), dated April 9, 1985 and April 10, 1985, respectively, which denied the petitioner’s applications for depth-of-lot variances to construct a number of residential homes on property owned by it in Levittown, New York, the appeals are from two judgments of the Supreme Court, Nassau County (Wager, J.), both entered June 10, 1986, which granted the petitions, annulled the board’s determinations, and directed the board to grant the variances requested by the petitioner subject to reasonable conditions.

Ordered that the judgments are reversed, on the law, with costs, the determinations are confirmed and the proceedings are dismissed on the merits.

The board’s determinations denying the petitioner’s variance applications had a rational basis, and, thus, should not have been overturned *(see, Matter of Fuhst v Foley,*45 NY2d 441, 444; *Matter of Cowan v Kern,*41 NY2d 591, 599, *rearg denied*42 NY2d 910; *Matter of Newman v Zoning Bd. of Appeals,*121 AD2d 543, *lv denied*68 NY2d 610). The evidence presented supported the conclusion that the petitioner would not suffer any " 'practical difficulties’ ” or significant economic injury as a result of the strict enforcement of the depth-of-lot requirements of the town’s zoning ordinance *(Matter of Fuhst v Foley, supra,*at 445; *see, Matter of Bauer v Zoning Bd. of Appeals, 121*AD2d 627, 628). To the contrary, the record undisputably indicates that the petitioner could make a substantial profit from developing the subject parcels even without the requested variances.

*765Moreover, the record supports the conclusion that the public benefit to be gained by strict enforcement of the subject zoning restriction outweighs any private detriment which might thereby be suffered by the petitioner *(see, Matter of De Sena v Board of Zoning Appeals,*45 NY2d 105, 108). The cumulative effect of granting the requested variances would be to create a development which would reduce open space, adversely affect the surrounding lots which are in strict conformity with the zoning ordinance’s 100-foot minimum depth-of-lot requirement *(see,*Building Zone Ordinance of Town of Hempstead § 193 [c]), and otherwise conflict with the general purposes of the Levittown Planned Residence District *(see,*Building Zone Ordinance of Town of Hempstead § 171). Thompson, J. P., Brown, Lawrence and Rubin, JJ., concur.
#### FERRIS, Respondent, v. FERRIS et al., Appellants.

(Supreme Court, Appellate Division, Second Department.

December 8, 1896.)

Action by Claiborne Ferris against A. Morton Ferris, Floyd Ferris, and William A. Kimball. Wheeler H. Peekham, for appellants. Esek Cowen, for respondent.

PER CURIAM.

We find no sufficient reason for interfering with the result reached by the learned referee who tried this case. The main purpose of the suit was to establish the liability of the defendant A. Morton Ferris for $25,000 deposited with the firm of A. M. Ferris & Kimball by the plaintiff in 1890. The defendants sought to show, in the first place, that the sum mentioned was paid to them, not as a special loan or deposit, as the plaintiff alleged, but upon an open and running account between them and the plaintiff relating to stock transactions; and for this reason they contended that he could not sue for it as a separate and independent obligation. Another branch of the defense was that, upon the dissolution of the firm of A. M. Ferris & Kimball, in 1892, and the formation of a new firm, known as “Ferris & Kimball,” in which A. Morton Ferris was not a partner, the old firm had been discharged from all liability on account of this $25,000. The evidence on both issues was conflicting, or such as to justify different inferences, depending upon the view which the trial court might take of the credibility of the witnesses and the significance to be attached, or the weight to be given, to the various items of documentary evidence, consisting largely of stockbrokers’ accounts. In passing upon the questions of fact, the referee has adopted the view which is most favorable to the plaintiff; and, in the absence of legal error affecting his determination, or unless that determination is against the weight of evidence, we cannot set it aside without virtually making this tribunal the trial court in his place and stead. The judgment should be affirmed, with costs.
**Exhibit 23.2**

**Consent of Independent Registered Public Accounting Firm**

We consent to the incorporation byreference in the Registration Statements (Form S-3 No. 333-138073 and Form S-8 Nos. 333-31751, 333-67265, 333-62618, 333-107462, 333-118041, 333-136406 and 333-144462) of NMT Medical, Inc. and in the related Prospectus of our report datedMarch 9, 2007, with respect to the consolidated financial statements of NMT Medical, Inc., included in the Annual Report (Form 10-K) for the year ended December 31, 2006. 

/s/ Ernst & Young LLP 

Boston,Massachusetts 

March 11, 2009
#### HARRIS, Respondent, v. UNION EL. R. Co., Appellant.

(Supreme Court, General Term, Second Department.

May 14, 1894.)

Appeal from circuit court, Kings county.

Action by Henry Frederick Harris against the Union Elevated Railroad Company.

Hoadly, Lauterbach & Johnson (Wm. N. Cohen and Frederick P. Delafield, of counsel), for appellant.

Stephen M. Hoye (Francis Russel Whitney, of counsel), for respondent.

PRATT, J.

There are no questions of law that require discussion. The witness James was clearly incompetent to testify as to the change produced in the rental value of Hudson avenue by the construction, of the road. The question of fact as to the amount of depreciation of the rental value by the road was determined favorably to defendant. The evidence would have justified a much larger verdict. We find no errors, and the judgment is affirmed, with costs.
#### O’CONNELL, Respondent, v. CLARK et al., Appellants.

(Supreme Court, Appellate Division, Second Department.

October 6, 1896.)

Action by James O’Connell against John Clark and William Clark.

No opinion. The court is without a quorum to decide this motion. It must be resubmitted. See 39 N. Y. Supp. 454.
Exhibit 23.2


                     Consent of Independent Auditors



The Board of Directors
Trigon Healthcare, Inc.:


We consent to incorporation by reference in the registration statement (No.
333-26187) on Form S-8 of Trigon Healthcare, Inc. of our report dated April 23,
1999, relating to the statements of financial condition of the Trigon
Healthcare, Inc. Employee Stock Purchase Plan as of December 31, 1998 and 1997,
and the related statements of income and changes in plan equity for the year
ended December 31, 1998 and the period May 1, 1997 (inception) through December
31, 1997, which report is included in this Form 10-K/A No.
1 of Trigon Healthcare, Inc.


/s/ KPMG LLP


Richmond, Virginia
April 29, 1999
#### The People of the State of New York, Respondent, v Amado Andrade, Appellant.

[946 NYS2d 880]

— Appeal by the defendant from an order of the County Court, Suffolk County (Kahn, J.), dated July 8, 2011, which, after a hearing, designated him a level three sex offender pursuant to Correction Law article 6-C.

Ordered that the appeal is dismissed as academic, without costs or disbursements.

In an order dated July 8, 2011, the County Court, after a hearing pursuant to the Sex Offender Registration Act (Correction Law art 6-C), designated the defendant a level three sex offender. The defendant filed the instant appeal, which is from the order dated July 8, 2011, arguing that several points were improperly assessed against him in connection with certain risk factors in the risk assessment instrument, and that he should be designated a level two sex offender. Subsequently, the County Court, in an order dated January 30, 2012, granted the defendant’s petition for a modification of his risk level designation from a level three sex offender to a level two sex offender. Thus, the defendant has already obtained the relief he seeks on this *1031appeal. Under these circumstances, the order dated January 30, 2012, has rendered the issues raised on this appeal academic and, consequently, this appeal must be dismissed as academic *(see Matter of Hearst Corp. v*Clyne, 50 NY2d 707, 714 [1980]; *Matter of Alexander v New York State Bd. of Parole,*175 AD2d 526, 527 [1991]). Rivera, J.P., Dickerson, Hall and Miller, JJ., concur.
**EXHIBIT      32**

**CERTIFICATE      OF CHIEF EXECUTIVE OFFICER AND **

**PRINCIPAL      FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE **

**SARBANES-OXLEY      ACT OF 2002 (18 U.S.C. 1350)**

|  | 1. | The                  Report fully complies with the requirements of Section 13(a) or                  15(d) of                  the Securities Exchange Act of 1934;                  and |
|--|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | 2. | The                  information contained in the Report fairly presents, in all material                  respects, the financial results of operations of the                  Company. |
|--|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                                                                                                                                                                       |   |   |   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|--------|
| /s/ Alan                    Doyle                                                                                                                                                     |   |   |   |
|                                                                                                                                                                                            |   |   |   |
| Alan                      DoylePresident                      (Chief Executive Officer),Treasurer                      (Principal Financial Officer)December                      13, 2006 |   |   |        |

----
EXHIBIT 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO



SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of The Thaxton Group, Inc. (the Company)
on Form 10-Q for the period ended June 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, James D. Thaxton., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350,
as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:



|(1) |  | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- |  | ---------------------------------------------------------------------------------------------------------------------



|(2) |  | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------



| |  | /s/ James D. ThaxtonJames D. Thaxton Chief Executive Officer
August 11, 2003
| |  | ----------------------------------------------------------------------------



This certification accompanies this
Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
# C_2021491EN.01000101.xml

| 7.12.2021 | EN | Official Journal of the European Union | C 491/1 |
| --- | --- | --- | --- |

7.12.2021

EN

Official Journal of the European Union

C 491/1

---

Notice for the attention of persons subject to the restrictive measures provided for in Council Decision (CFSP) 2020/1999, as amended by Council Decision (CFSP) 2021/2160and in Council Regulation (EU) 2020/1998, as implemented by Council Implementing Regulation (EU) 2021/2151 concerning restrictive measures against serious human rights violations and abuses

(2021/C 491/01)

The following information is brought to the attention of the persons that appear in the Annex to Council Decision (CFSP) 2020/1999 (1), as amended by Council Decision (CFSP) 2021/2160 (2), and in Annex I to Council Regulation (EU) 2020/1998 (3) as implemented by Council Implementing Regulation (EU) 2021/2151 (4), concerning restrictive measures against serious human rights violations and abuses.

The Council of the European Union has decided that those persons should be maintained on the list of persons subject to restrictive measures provided for in Decision (CFSP) 2020/1999 and Regulation (EU) 2020/1998. The grounds for designations of those persons appear in the relevant entries in those Annexes.

The attention of the persons concerned is drawn to the possibility of making an application to the competent authorities of the relevant Member State(s) as indicated in the websites in Annex II to Regulation (EU) 2020/1998, in order to obtain an authorisation to use frozen funds for basic needs or specific payments (cf. Article 4 of the Regulation).

The persons concerned may submit a request to the Council before 31 July 2022, together with supporting documentation that the decision to include them on the above-mentioned list should be reconsidered, to the following address:

| Council of the European Union |
| --- |
| General Secretariat |
| RELEX.1.C |
| Rue de la Loi/Wetstraat 175 |
| 1048 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

Council of the European Union

General Secretariat

RELEX.1.C

Rue de la Loi/Wetstraat 175

1048 Bruxelles/Brussel

BELGIQUE/BELGIË

Email: sanctions@consilium.europa.eu

Any observations received will be taken into account for the purpose of the Council’s periodic review, pursuant to Article 10 of Decision (CFSP) 2020/1999, of the list of designated persons and entities.

---

(1)  OJ L 410 I , 7.12.2020, p. 13.

(2)  OJ L 436, 7.12.2021, p. 40.

(3)  OJ L 410 I , 7.12.2020, p. 1.

(4)  OJ L 436, 7.12.2021, p. 1.

---
# C_2021215EN.01000101.xml

| 7.6.2021 | EN | Official Journal of the European Union | C 215/1 |
| --- | --- | --- | --- |

7.6.2021

EN

Official Journal of the European Union

C 215/1

---

Non-opposition to a notified concentration

(Case M.9695 — LVMH/Tiffany)

(Text with EEA relevance)

(2021/C 215/01)

On 26 October 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9695. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9695. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
# C_2021484EN.01000301.xml

| 2.12.2021 | EN | Official Journal of the European Union | C 484/3 |
| --- | --- | --- | --- |

2.12.2021

EN

Official Journal of the European Union

C 484/3

---

Non-opposition to a notified concentration

(Case M.10075 – Nexi/Nets Group)

(Text with EEA relevance)

(2021/C 484/03)

On 8 March 2021, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10075. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32021M10075. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

---
# C_2021459EN.01001501.xml

| 12.11.2021 | EN | Official Journal of the European Union | C 459/15 |
| --- | --- | --- | --- |

12.11.2021

EN

Official Journal of the European Union

C 459/15

---

EUROPEAN CHEMICALS AGENCY

Publication of the final accounts for the financial year 2020

(2021/C 459/15)

The complete version of the final accounts may be found at the following address:

https://echa.europa.eu/documents/10162/23711/echa_annual_accounts_2020_en.pdf/8ae7fc69-6c59-93c7-8a38-2931f23ad26a?t=1625048899884

---
[Federal Register Volume 65, Number 74 (Monday, April 17, 2000)]
[Notices]
[Page 20473]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-9434]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 522b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Mentored Clinical Scientist Development 
Awards (K08).
    Date: April 12, 2000.
    Time: 2:30 PM to 4 PM.
    Agenda: To review and evaluate grant applications.
    Place: 6701 Rockledge Drive, Room 7214, Bethesda, MD 20892 
(Telephone Conference Call).
    Contact Person: C. James Scheirer, PhD, Chief, Review Branch, 
Division of Extramural Affairs, National Heart, Lung, and Blood 
Institute, Rockledge Center II, 6701 Rockledge Drive, Suite 7216, 
Bethesda, MD 20892-7924, 301-435-0266.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Disease Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: April 6, 2000.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-9434 Filed 4-14-00; 8:45 am]
BILLING CODE 4140-01-M